Role of biologically modified low-density lipoprotein in atherosclerosis
- 1 October 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 64 (13) , G18-G22
- https://doi.org/10.1016/0002-9149(89)90951-x
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic RabbitsScience, 1988
- Superoxide initiates oxidation of low density lipoprotein by human monocytes.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It CytotoxicJournal of Leukocyte Biology, 1985
- Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.Journal of Clinical Investigation, 1984
- Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
- Lipoproteins and atherosclerosis. A look back and a look ahead.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Lipoprotein oxidation and lipoprotein-induced cytotoxicity.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Enhanced macrophage degradation of biologically modified low density lipoprotein.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977